{"generic":"Calcium Chloride","drugs":["Calcium Chloride"],"mono":{"0":{"id":"99680-s-0","title":"Generic Names","mono":"Calcium Chloride"},"1":{"id":"99680-s-1","title":"Dosing and Indications","sub":[{"id":"99680-s-1-4","title":"Adult Dosing","mono":"<ul><li>contains 100 mg calcium chloride per mL; 27.3 mg or 1.36 mEq of elemental calcium per mL<\/li><li><b>Hypocalcemia:<\/b> 200 mg to 1 g calcium chloride (2 to 10 mL of a 10% solution; 55 to 273 mg elemental calcium) IV every 1 to 3 days; MAX rate, 1 mL\/min<\/li><\/ul>"},{"id":"99680-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>contains 100 mg calcium chloride per mL; 27.3 mg or 1.36 mEq of elemental calcium per mL<\/li><li><b>Advanced cardiac life support:<\/b> 20 mg\/kg calcium chloride (0.2 mL\/kg of 10% solution; 5.5 mg\/kg elemental calcium) IV or INTRAOSSEOUS; administer slowly; MAX dose 2 g calcium chloride (546 mg elemental calcium)<\/li><li><b>Hypocalcemia:<\/b> 2.7 to 5 mg\/kg calcium chloride (0.027 to 0.05 mL\/kg of a 10% solution; 0.74 to 1.37 mg\/kg elemental calcium) IV every 4 to 6 hours; MAX rate, 1 mL\/min<\/li><\/ul>"},{"id":"99680-s-1-6","title":"Dose Adjustments","mono":"<ul><li><b>renal impairment:<\/b> CrCl less than 25 mL\/min, base dosing on serum calcium levels<\/li><li><b>renal impairment:<\/b> chronic hemodialysis, dosage reduction may be necessary due to potential for the development of hypercalcemia<\/li><\/ul>"},{"id":"99680-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Hypocalcemia<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Advanced cardiac life support<\/li><li>General anesthesia; Adjunct<\/li><\/ul>"}]},"3":{"id":"99680-s-3","title":"Contraindications\/Warnings","sub":[{"id":"99680-s-3-9","title":"Contraindications","mono":"<ul><li>use of ceftriaxone sodium injection in neonates receiving or expected to receive calcium-containing IV solutions<\/li><li>ventricular fibrillation during cardiac resuscitation<\/li><\/ul>"},{"id":"99680-s-3-10","title":"Precautions","mono":"<ul><li>concomitant use of digitalis drugs not recommended unless indications are clearly defined<\/li><li>IM, subQ, or injection into perivascular tissue may cause necrosis and skin sloughing<\/li><li>injection rate greater than 0.5 to 1 mL\/min not recommended<\/li><li>renal impairment; CNS toxicity, bone toxicity, and tissue loading may result from aluminum accumulation associated with prolonged parenteral administration; premature neonates are at increased risk<\/li><\/ul>"},{"id":"99680-s-3-11","title":"Pregnancy Category","mono":"Calcium: C (FDA)<br\/>"},{"id":"99680-s-3-12","title":"Breast Feeding","mono":"Calcium: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"99680-s-4","title":"Drug Interactions","sub":[{"id":"99680-s-4-13","title":"Contraindicated","mono":"<ul><li>Ceftriaxone (probable)<\/li><li>Digitoxin (probable)<\/li><\/ul>"},{"id":"99680-s-4-14","title":"Major","mono":"<ul><li>Digoxin (probable)<\/li><li>Eltrombopag (established)<\/li><li>Ketoconazole (probable)<\/li><\/ul>"},{"id":"99680-s-4-15","title":"Moderate","mono":"<ul><li>Chlorothiazide (probable)<\/li><li>Chlortetracycline (probable)<\/li><li>Ciprofloxacin (probable)<\/li><li>Dasatinib (established)<\/li><li>Demeclocycline (probable)<\/li><li>Dolutegravir (established)<\/li><li>Doxycycline (probable)<\/li><li>Enoxacin (probable)<\/li><li>Grepafloxacin (probable)<\/li><li>Levofloxacin (probable)<\/li><li>Lomefloxacin (probable)<\/li><li>Methacycline (probable)<\/li><li>Minocycline (probable)<\/li><li>Norfloxacin (probable)<\/li><li>Oxytetracycline (probable)<\/li><li>Pefloxacin (probable)<\/li><li>Rolitetracycline (probable)<\/li><li>Sodium Polystyrene Sulfonate (probable)<\/li><li>Sparfloxacin (probable)<\/li><li>Strontium Ranelate (probable)<\/li><li>Tetracycline (probable)<\/li><li>Ticlopidine (probable)<\/li><li>Zalcitabine (probable)<\/li><\/ul>"}]},"5":{"id":"99680-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Burning sensation<br\/><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Vasodilatation<\/li><li><b>Dermatologic:<\/b>Necrosis<\/li><\/ul>"},"6":{"id":"99680-s-6","title":"Drug Name Info","sub":{"2":{"id":"99680-s-6-19","title":"Class","mono":"Parenteral Mineral-Trace Mineral<br\/>"},"3":{"id":"99680-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"99680-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"99680-s-7","title":"Mechanism Of Action","mono":"Calcium is an important mineral which is responsible for strong bones and is also used by the body for proper muscle contraction and nerve function.<br\/>"},"8":{"id":"99680-s-8","title":"Pharmacokinetics","sub":{"0":{"id":"99680-s-8-23","title":"Absorption","mono":"<ul><li>Bioavailability, Oral: 4% to 45%<\/li><li>Effect of food: Increased absorption<\/li><\/ul>"},"1":{"id":"99680-s-8-24","title":"Distribution","mono":"Protein binding: 45% <br\/>"},"3":{"id":"99680-s-8-26","title":"Excretion","mono":"Renal clearance: 50 to 300 mg\/day.<br\/>"}}},"9":{"id":"99680-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>do not give by IM or subQ route<br\/><\/li><li><b>Intravenous<\/b><br\/><ul><li>administer as slow IV injection (not to exceed 1 mL\/min) through a small needle into a large vein; preferably in a central or deep vein<\/li><li>patient should remain recumbent for a short time following injection<\/li><\/ul><\/li><li><b>Intraventricular<\/b><br\/>may inject into the ventricular cavity during cardiac resuscitation; avoid injection into the cardiac muscle<br\/><\/li><\/ul>"},"10":{"id":"99680-s-10","title":"Monitoring","mono":"<ul><li>serum calcium levels<\/li><li>symptomatic improvement<\/li><\/ul>"},"11":{"id":"99680-s-11","title":"How Supplied","mono":"<b>Generic<\/b><br\/>Intravenous Solution: 100 MG\/ML<br\/>"},"13":{"id":"99680-s-13","title":"Clinical Teaching","mono":"<ul><li>Instruct patients with renal impairment and caregivers of premature neonates to report signs\/symptoms of CNS and bone toxicity.<\/li><li>Advise patients to report signs\/symptoms of extravasation, including necrosis and sloughing.<\/li><\/ul>"}}}